Name: 82nd Heidelberg Grand Round - Novel cell based immunotherapy strategies
Start: 2025-12-11T16:00:00+01:00
End: 2025-12-11T18:00:00+01:00
Location: German Cancer Research Center (DKFZ)

82nd Heidelberg Grand Round - Novel cell based immunotherapy strategies

Thursday, December 11, 2025 - 4:00 PM

Monday, December 8, 2025
Tuesday, December 9, 2025
Wednesday, December 10, 2025
Thursday, December 11, 2025
4:00 PM Welcome and opening remarks - Dirk Jäger (Heidelberg University Hospital (UKHD), German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT) Heidelberg) Christian Seitz (Heidelberg University Hospital (UKHD), German Cancer Research Center (DKFZ), Hopp Children`s Cancer Center Heidelberg (KiTZ), National Center for Tumor Diseases (NCT) Heidelberg) Carsten Müller-Tidow (Heidelberg University Hospital (UKHD), Heidelberg University, National Center for Tumor Diseases (NCT) Heidelberg)
Welcome and opening remarks
- Dirk Jäger (Heidelberg University Hospital (UKHD), German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT) Heidelberg)
- Christian Seitz (Heidelberg University Hospital (UKHD), German Cancer Research Center (DKFZ), Hopp Children`s Cancer Center Heidelberg (KiTZ), National Center for Tumor Diseases (NCT) Heidelberg)
- Carsten Müller-Tidow (Heidelberg University Hospital (UKHD), Heidelberg University, National Center for Tumor Diseases (NCT) Heidelberg)
4:00 PM - 4:01 PM
Room: Kommunikationszentrum (Lecture Hall)
4:01 PM The next frontiers in CAR T cell therapy - Carsten Müller-Tidow (Heidelberg University Hospital (UKHD), Heidelberg University, National Center for Tumor Diseases (NCT) Heidelberg)
The next frontiers in CAR T cell therapy
- Carsten Müller-Tidow (Heidelberg University Hospital (UKHD), Heidelberg University, National Center for Tumor Diseases (NCT) Heidelberg)
4:01 PM - 4:30 PM
Room: Kommunikationszentrum (Lecture Hall)
4:30 PM GD2-CART01 for pediatric solid tumors: breakthroughs, challenges and path forward - Francesca del Bufalo (Bambino Gesù Children's Hospital, Italy)
GD2-CART01 for pediatric solid tumors: breakthroughs, challenges and path forward
- Francesca del Bufalo (Bambino Gesù Children's Hospital, Italy)
4:30 PM - 5:00 PM
Room: Kommunikationszentrum (Lecture Hall)
5:00 PM PRAMEtime - TCR-engineered T cell therapy in pediatric oncology - Christian Seitz (Heidelberg University Hospital (UKHD), German Cancer Research Center (DKFZ), Hopp Children`s Cancer Center Heidelberg (KiTZ), National Center for Tumor Diseases (NCT) Heidelberg)
PRAMEtime - TCR-engineered T cell therapy in pediatric oncology
- Christian Seitz (Heidelberg University Hospital (UKHD), German Cancer Research Center (DKFZ), Hopp Children`s Cancer Center Heidelberg (KiTZ), National Center for Tumor Diseases (NCT) Heidelberg)
5:00 PM - 5:30 PM
Room: Kommunikationszentrum (Lecture Hall)
5:30 PM Personalized adoptive T cell therapy using vaccination site-infiltrating lymphocytes in patients with metastatic cancer - Marten Meyer (German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD), National Center for Tumor Diseases (NCT) Heidelberg)
Personalized adoptive T cell therapy using vaccination site-infiltrating lymphocytes in patients with metastatic cancer
- Marten Meyer (German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD), National Center for Tumor Diseases (NCT) Heidelberg)
5:30 PM - 6:00 PM
Room: Kommunikationszentrum (Lecture Hall)

Choose timezone